Skip to content

Clinical study of modified curettage for medication-related osteonecrosis of the jaw

Clinical study of modified curettage for medication-related osteonecrosis of the jaw

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027382
Enrollment
Unknown
Registered
2019-11-11
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

medication-related osteonecrosis of the jaw, MRONJ

Interventions

group1:curettage
group2:curretage plus bone tunnel preparation

Sponsors

Peking University Hospital of Stomotology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 100 Years

Inclusion criteria

Inclusion criteria: According to the MRONJ diagnosis standard; stratified into stage II; general body condition can tolerate surgery; agree to receive curettage surgery; sign informed consent.

Exclusion criteria

Exclusion criteria: Preoperative diagnosis as MRONJ, but the postoperative specimen was diagnosed as metastatic tumor; the follow-up of the patient was lost after surgery.

Design outcomes

Primary

MeasureTime frame
Status evaluation of bone exposure or mucosa/skin fistula;Status evaluation of bone exposure or mucosa/skin fistula;Status evaluation of bone exposure or mucosa/skin fistula;bony wound healing;

Secondary

MeasureTime frame
University of Washington Quality of Life Questionnaire (UW-QOL, V4.0);University of Washington Quality of Life Questionnaire (UW-QOL, V4.0);

Countries

China

Contacts

Public ContactGuo Yuxing

Peking University Hospital of Stomotology

gladiater1984@163.com+86 15101126779

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026